Cross-clade neutralization of HIV-1 by a monoclonal antibody obtained by immunization with liposomes containing lipid A and a synthetic MPER peptide

Cross-clade neutralization of HIV-1 by a monoclonal antibody obtained by immunization with liposomes containing lipid A and a synthetic MPER peptide

Bibliographic Details
Main Authors:	Matyas GR, Jobe O, Wieczorek L, Peachman KK, Beck Z, Polonis VR, Rao M, Alving CR
Format:	Article
Language:	English
Published:	BMC 2012-09-01
Series:	Retrovirology

Similar Items

P04-19. Analysis of the binding of multiple clades of HIV-1 by a modified virus capture assay
by: Alving CR, et al.
Published: (2009-10-01)

P04-22. Multispecific monoclonal antibodies bind to primary human macrophages and induce the production of protective chemokines, MIP-1α and MIP-1β
by: Alving CR, et al.
Published: (2009-10-01)

P05-04. Neutralizing antibodies induced by immunization with liposomal gp41 peptide simultaneously bind to both the 2F5 or 4E10 epitope and lipid epitopes
by: Polonis VR, et al.
Published: (2009-10-01)

P12-08. Membrane-specific antibodies that simultaneously bind to gp41 of HIV-1 and membrane lipid epitopes are induced by immunization with liposomes
by: Alving CR, et al.
Published: (2009-10-01)

Soluble and bacteriophage T4 displayed gp41 mutant proteins as HIV-1 vaccine candidates
by: Gao G, et al.
Published: (2012-09-01)

Human erythrocytes selectively bind and enrich infectious HIV-1 virions.
by: Zoltan Beck, et al.
Published: (2009-01-01)

OBTAINING CHIMERIC VARIANTS HBcAg EXPOSING HIV-1 MPER FRAGMENTS
by: A. P. Rudometov, et al.
Published: (2019-09-01)

Chimeric rhinoviruses displaying MPER epitopes elicit anti-HIV neutralizing responses.
by: Guohua Yi, et al.
Published: (2013-01-01)

Refined identification of neutralization-resistant CRF02_AG viruses and their sensitivity to anti-MPER neutralizing antibodies
by: Jacob RA, et al.
Published: (2012-09-01)

Multimeric scaffolds displaying the HIV-1 envelope MPER induce MPER-specific antibodies and cross-neutralizing antibodies when co-immunized with gp160 DNA.
by: Shelly J Krebs, et al.
Published: (2014-01-01)

Correction: Multimeric scaffolds displaying the HIV-1 envelope MPER induce MPER-specific antibodies and cross-neutralizing antibodies when co-immunized with gp160 DNA.
by: PLOS ONE Staff
Published: (2015-01-01)

Developmental Pathway of the MPER-Directed HIV-1-Neutralizing Antibody 10E8.
by: Cinque Soto, et al.
Published: (2016-01-01)

Correction: Chimeric Rhinoviruses Displaying MPER Epitopes Elicit Anti-HIV Neutralizing Responses.
by: Guohua Yi, et al.
Published: (2013-01-01)

An MPER antibody neutralizes HIV-1 using germline features shared among donors
by: Lei Zhang, et al.
Published: (2019-11-01)

Eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER
by: Han D, et al.
Published: (2012-09-01)

SCN-AVP release of <it>mPer1/mPer2 </it>double-mutant mice in vitro
by: Oster Henrik, et al.
Published: (2008-03-01)

Affinity maturation pathway of an anti-MPER neutralizing mAb, CAP206-CH12
by: Tumba NL, et al.
Published: (2012-09-01)

Dependence on a variable residue limits the breadth of an HIV MPER neutralizing antibody, despite convergent evolution with broadly neutralizing antibodies.
by: Cathrine Scheepers, et al.
Published: (2022-09-01)

Antibody to gp41 MPER alters functional properties of HIV-1 Env without complete neutralization.
by: Arthur S Kim, et al.
Published: (2014-07-01)

P19-50. Simulation of an MPER peptide samples epitope conformations of two broadly neutralizing antibodies
by: Schmidler SC, et al.
Published: (2009-10-01)

Malaysian private entities reporting standard (MPERS) /
by: 867 Malaysian Accounting Standards Board
Published: (2016)

Similarities and differences of chemical compositions and physical and functional properties of adjuvant system 01 and army liposome formulation with QS21
by: Carl R. Alving, et al.
Published: (2023-01-01)

A comprehensive binding and neutralization analysis of plasma of HIV-1 subtype-C infected donors from India suggest MPER directed neutralization
by: Andrabi R, et al.
Published: (2012-09-01)

Heroin-HIV-1 (H2) vaccine: induction of dual immunologic effects with a heroin hapten-conjugate and an HIV-1 envelope V2 peptide with liposomal lipid A as an adjuvant
by: Oscar B. Torres, et al.
Published: (2017-05-01)

A gp41 MPER-specific llama VHH requires a hydrophobic CDR3 for neutralization but not for antigen recognition.
by: David Lutje Hulsik, et al.
Published: (2013-03-01)

Targeted modification of the Per2 clock gene alters circadian function in mPer2luciferase (mPer2Luc) mice.
by: Martin R Ralph, et al.
Published: (2021-05-01)

The impact of differences in viral entry and trafficking on the mechanism of HIV-1 neutralization
by: Cincotta CD, et al.
Published: (2012-09-01)

P04-06. Evolution of an anti-MPER gp41 antibody response that mediates broad HIV-1 cross-neutralization
by: Abdool-Karim S, et al.
Published: (2009-10-01)

A gp41 MPER-specific llama VHH requires a hydrophobic CDR3 determinant for neutralization but not for antigen recognition
by: Weissenhorn W, et al.
Published: (2012-09-01)

HIV-1 Envelope and MPER Antibody Structures in Lipid Assemblies
by: Kimmo Rantalainen, et al.
Published: (2020-04-01)

CoPoP liposomes displaying stabilized clade C HIV-1 Env elicit tier 2 multiclade neutralization in rabbits
by: Annemart Koornneef, et al.
Published: (2024-04-01)

The Gp41 Sequence Connecting Mper and Tm Domains Constitutes a Distinct HIV-1 "Fusion Peptide" Targeted by Neutralizing Antibodies
by: Apellaniz, B, et al.
Published: (2014)

Detection of Novel Neutralizing Antibody Reactivities Against The Membrane Proximal External Region (MPER) of gp41 in HIV-1 Infected Humans
by: Shaw George M
Published: (2005-12-01)

Neutralization of tier-2 viruses and epitope profiling of plasma antibodies from subtype-C HIV-1 infected north Indians; implications for MPER directed HIV-1 neutralization
by: Andrabi Raiees, et al.
Published: (2012-05-01)

Low levels of anti-MPER antibodies are detectable in viremic HIV infected
by: Carrillo J, et al.
Published: (2012-09-01)

Exposure of the HIV-1 broadly neutralizing antibody 10E8 MPER epitope on the membrane surface by gp41 transmembrane domain scaffolds
by: Oakes, V, et al.
Published: (2018)

Induction of HIV neutralizing antibodies against the MPER of the HIV envelope protein by HA/gp41 chimeric protein-based DNA and VLP vaccines.
by: Ling Ye, et al.
Published: (2011-01-01)

Membrane-Active Sequences within gp41 Membrane Proximal External Region (MPER) Modulate MPER-Containing Peptidyl Fusion Inhibitor Activity and the Biosynthesis of HIV-1 Structural Proteins
by: Zhang, Si Min, et al.
Published: (2015)

Membrane-Active Sequences within gp41 Membrane Proximal External Region (MPER) Modulate MPER-Containing Peptidyl Fusion Inhibitor Activity and the Biosynthesis of HIV-1 Structural Proteins.
by: Si Min Zhang, et al.
Published: (2015-01-01)

QS21-Initiated Fusion of Liposomal Small Unilamellar Vesicles to Form ALFQ Results in Concentration of Most of the Monophosphoryl Lipid A, QS21, and Cholesterol in Giant Unilamellar Vesicles
by: Erwin G. Abucayon, et al.
Published: (2023-08-01)